Ocular Therapeutix
OCUL
$4.64
Share price
-7.10%
Change (1 day)
-25.08%
Change (1 year)
Categories
Earnings for Ocular Therapeutix (OCUL)
Earnings in 2023 (TTM): -$80.74 M
According to Ocular Therapeutix's latest financial reports the company's current earnings (TTM) are -$80.74 M. In 2022 the company made an earning of -$71.04 M a decrease over its 2021 earnings that were of -$6.56 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Ocular Therapeutix from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$80.74 M | 13.65% |
| 2022 | -$71.04 M | 984.05% |
| 2021 | -$6.56 M | -95.79% |
| 2020 | -$0.16 B | 80.19% |
| 2019 | -$86.38 M | 44.01% |
| 2018 | -$59.98 M | -5.38% |
| 2017 | -$63.39 M | 41.79% |
| 2016 | -$44.71 M | 12.47% |
| 2015 | -$39.75 M | 38.75% |
| 2014 | -$28.65 M | 115.12% |
| 2013 | -$13.32 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $13.33 M | -116.51% | 🇺🇸 USA |
 Anika Therapeutics ANIK | -$25.45 M | -68.48% | 🇺🇸 USA |
 Intersect ENT XENT | -$0.17 B | 99.82% | 🇺🇸 USA |
 Haemonetics HAE | $0.17 B | -310.80% | 🇺🇸 USA |